After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
VYGR belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Voyager Therapeutics Inc is $190.26M. A total of 0.61 million shares were traded on the day, compared to an average of 780.43K shares.
In the most recent transaction, Ferguson Toby sold 19,000 shares of VYGR for 3.73 per share on Aug 18 ’25. After the transaction, the Chief Medical Officer now owns 138,914 company shares. In a previous transaction on Aug 18 ’25, Ferguson Toby bought 19,000 shares at 3.72 per share.
Among the insiders who sold shares, Ferguson Toby disposed of 10,086 shares on Apr 02 ’25 at a per-share price of $3.43. This resulted in the Chief Medical Officer holding 157,914 shares of VYGR after the transaction. In another insider transaction, Sandrock Alfred sold 10,885 shares at $3.43 per share on Apr 02 ’25. Company shares held by the President and CEO now total 430,931.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, VYGR has a high of $8.27 and a low of $2.64.
As of this writing, VYGR has an earnings estimate of -$0.52 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.32 per share and a lower estimate of -$0.6. The company reported an EPS of -$0.16 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. VYGR’s latest balance sheet shows that the firm has $132.54M in Cash & Short Term Investments as of fiscal 2021. There were $44.18M in debt and $50.98M in liabilities at the time. Its Book Value Per Share was $4.40, while its Total Shareholder’s Equity was $95.06M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VYGR is Buy with a score of 4.83.
